← Leaderboards
Gautam (george) Mitra
Leidos Biomedical Research, Inc.
$53,523,213
Attributed
$53,523,213
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $33.3M · FY2018–24$50M$37.5M$25M$12.5M$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$53,523,213 · 1
By mechanism
N01$33,303,879 · 1
N02$20,219,334 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Leonard Freedman$1,216,107,431
- Ralph Parchment$197,348,011
- Ethan Dmitrovsky$597,515,186
- Lynn Briscoe$495,968,635
Others in their field
Other Emerging Leaders on “Natural Killer Cells”
- Paul John Norman · University Of Colorado Denver$13,162,878
- Wilton B Williams · Duke University$11,648,165
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$10,801,454
- Deanna A Kulpa · Emory University$8,444,989
- Sandhya Vasan · Henry M. Jackson Fdn For The Adv Mil/Med$7,776,394
- Emily Margaret Mace · Columbia University Health Sciences$6,560,188
Research focus
Natural Killer CellsPharmacodynamic BiomarkerMonitorMulti-Institutional Clinical TrialNeedlesAnimal TestingAnalytical MethodManufacturing ProcessAllogenicCellular ImmunotherapyAutologousClinical TrialsDivision Of Cancer Treatment And DiagnosisBiological ProductsEvaluable DiseaseBiopsyFreezingCellsLaboratoriesCell TherapyLeukemiaLymphomaClinical ResearchPharmacodynamics